Literature DB >> 9020392

Pathologic assessment of cerebellar atrophy following acute lithium intoxication.

W E Mangano1, T J Montine, C M Hulette.   

Abstract

Lithium carbonate is a widely used pharmacologic agent for acute bipolar disorder, long term prophylaxis of mania in a bipolar patient, and prevention of "manic overshoot" with an antidepressant in acute depression in a bipolar patient. Although clinical neurological associations with lithium overdose have been-established, there has been a dearth of reports of pathologic changes related to lithium toxicity. We report a case of a 52-year-old Black female with bipolar disorder who had been treated with lithium for over 5 years and who expired 24 days after presenting in a stuporous state with an elevated lithium level of 3.2 mEq/l. Postmortem neuropathologic examination revealed severe cerebellar atrophy of the internal granule and Purkinje cell layers with attendant Bergmann gliosis presumably resulting from chronic lithium use and toxicity. There was also Alzheimer type II cell change in the thalamus and lentiform nuclei possibly due to terminal uremia. In summary, this is a unique case which appears to illustrate cerebellar atrophic changes related to lithium therapy and acute lithium intoxication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020392

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  3 in total

Review 1.  Permanent Cerebellar Degeneration After Acute Hyperthermia with Non-toxic Lithium Levels: a Case Report and Review of Literature.

Authors:  Fabian H Rossi; Elisa Marie Rossi; Michael Hoffmann; Welwin Liu; Ramon Rodriguez Cruz; Natasha Antonovich; Arash Rezaei; Elizabeth Gonzalez; Maria Clara Franco; Alvaro Estevez; Florian Thomas
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  Lithium overdose and delayed severe neurotoxicity: timing for renal replacement therapy and restarting of lithium.

Authors:  Angharad N de Cates; Julien Morlet; Ayman Antoun Reyad; George Tadros
Journal:  BMJ Case Rep       Date:  2017-10-25

3.  Abnormalities in brain structure and behavior in GSK-3alpha mutant mice.

Authors:  Oksana Kaidanovich-Beilin; Tatiana V Lipina; Keizo Takao; Matthijs van Eede; Satoko Hattori; Christine Laliberté; Mustafa Khan; Kenichi Okamoto; John W Chambers; Paul J Fletcher; Katrina MacAulay; Bradley W Doble; Mark Henkelman; Tsuyoshi Miyakawa; John Roder; James R Woodgett
Journal:  Mol Brain       Date:  2009-11-19       Impact factor: 4.041

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.